Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 11—November 2026
Dispatch
Middle East Respiratory Syndrome Coronavirus in Camels, Kazakhstan, 2025
Aidyn Kydyrmanov1
, Yermukhammet Kassymbekov, Sardor Nuralibekov, Temirlan Sabyrzhan, Yelizaveta Khan, Marat Kumar, Aigerim Abdimadiyeva, and Kobey Karamendin1
, Yermukhammet Kassymbekov, Sardor Nuralibekov, Temirlan Sabyrzhan, Yelizaveta Khan, Marat Kumar, Aigerim Abdimadiyeva, and Kobey Karamendin1
Table
Results of quantitative reverse transcription PCR of nasopharyngeal swab samples positive for Middle East respiratory syndrome coronavirus, Kazakhstan, 2025*
| Camel species | Age, y | Consistent clinical signs | UpE, Ct | ORF1a, Ct | RdRp, bp | Sequenced† |
|---|---|---|---|---|---|---|
| Dromedary | 12 | Nasal discharge | 27.94 | 24.13 | 760 | NA |
| Dromedary | 10 | Nasal discharge | 30.80 | 26.60 | 760 | NA |
| Bactrian | <1 | Nasal discharge | 29.37 | 25.29 | 760 | NA |
| Bactrian | 6 | Nasal discharge | 26.90 | 22.50 | 760 | 760-nt RdRp |
| Dromedary | 4 | Nasal discharge | 34.30 | 30.13 | NA | NA |
| Dromedary | 13 | Nasal discharge | 33.40 | 29.78 | NA | NA |
| Dromedary | 10 | Nasal discharge | 31.65 | 28.25 | NA | NA |
| Dromedary | 12 | Nasal discharge | 27.20 | 22.30 | 760 | 760-nt RdRp and full spike gene |
| Bactrian | 12 | Nasal discharge | 28.43 | 25.97 | 440 | 440-nt RdRp and full spike gene |
| Bactrian | 8 | Nasal discharge | 30.60 | 27.00 | 440 | 440-nt RdRp |
| Bactrian | 12 | Nasal discharge | 28.90 | 24.70 | NA | NA |
| Dromedary | <1 | Nasal discharge | 23.56 | 20.66 | 760 | Whole genome |
| Dromedary | <1 | Nasal discharge | 26.55 | 22.40 | 760 | NA |
| Bactrian | 7 | Nasal discharge | 31.19 | 26.41 | NA | NA |
| Dromedary | 9 | Nasal discharge | 28.70 | 25.10 | NA | NA |
| Dromedary | 10 | Nasal discharge | 29.05 | 22.22 | NA | NA |
| Bactrian | 8 | Nasal discharge | 32.10 | 28.02 | NA | NA |
| Dromedary | 10 | Nasal discharge | 23.82 | 14.33 | 760 | Full spike gene |
| Dromedary | <1 | Nasal discharge | 33.09 | 30.61 | 760 | NA |
| Dromedary | 14 | Nasal discharge | 28.93 | 26.63 | 760 | NA |
| Dromedary | 6 | Nasal discharge | 30.40 | 27.10 | 760 | NA |
| Dromedary | <1 | Nasal discharge | 29.82 | 26.29 | NA | NA |
| Dromedary | 12 | Nasal discharge | 31.20 | 27.29 | NA | NA |
| Dromedary | 12 | Nasal discharge | 33.00 | 29.50 | NA | NA |
| Dromedary | 10 | Nasal discharge | 29.13 | 25.97 | NA | NA |
| Dromedary | 10 | Nasal discharge | 29.30 | 25.40 | NA | NA |
| Dromedary | 10 | Nasal discharge | 25.99 | 22.73 | 760 | NA |
| Dromedary | 14 | Nasal discharge | 28.60 | 24.70 | 760 | NA |
| Dromedary | 9 | Nasal discharge | 23.14 | 31.09 | NA | NA |
| Dromedary | 8 | Nasal discharge | 32.80 | 29.32 | NA | NA |
| Dromedary | 7 | Nasal discharge | 30.00 | 27.47 | NA | NA |
| Dromedary | 13 | Nasal discharge | 33.50 | 29.59 | NA | NA |
| Dromedary | 13 | Nasal discharge | 31.76 | 30.46 | NA | NA |
| Dromedary | 8 | Nasal discharge | 28.80 | 25.10 | NA | NA |
| Dromedary | 9 | Nasal discharge | 26.76 | 24.41 | NA | NA |
| Dromedary | 3 | Nasal discharge | 25.22 | 23.25 | NA | NA |
| Dromedary | 5 | Nasal discharge | 29.32 | 25.33 | NA | NA |
| Dromedary |
7 |
Nasal discharge |
28.40 |
25.72 |
NA |
NA |
| Median Ct |
29.31 | 25.89 | NA | NA | ||
*bp, base pair; Ct, cycle threshold; nt, nucleotide; NA, not applicable; ORF1a, open reading frame 1a; RdRp, RNA-dependent RNA polymerase; UpE, upstream envelope protein. †RdRp was amplified by using pancoronavirus RT-PCR and then selected amplicons were sequenced.
1These authors contributed equally to this work and share first and last authorship.
Page created: August 17, 2026
Page updated: October 16, 2026
Page reviewed: October 16, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.